Here is some news that, before too long, some of you may be able to use. There is a new technique for diagnosing prostate cancer. It is being deployed on an experimental basis at the National ...

The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) with targeted biopsies (MRI-TBx ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with ...

Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by ...

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

Please provide your email address to receive an email when new articles are posted on . Combining an MRI-targeted biopsy approach with the Stockholm3 blood test for prostate cancer screening reduced ...